Reversal of alopecia universalis by tofacitinib: A case report

Annals of Internal Medicine

Volumn 165, Issue 10, 2016, Pages 750-751

  Scheinberg, Morton ^a   Ferreira, Sineida Berbert ^b  

^a HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^b Clinica Dermatosineida   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; METHOTREXATE; MINOXIDIL; TOFACITINIB; JANUS KINASE 1; JANUS KINASE 3; JANUS KINASE INHIBITOR; PIPERIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADULT; ALOPECIA; ALOPECIA UNIVERSALIS; CASE REPORT; DRUG EFFECT; FEMALE; HUMAN; LETTER; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; ANTAGONISTS AND INHIBITORS; YOUNG ADULT;

ADULT; ALOPECIA; FEMALE; HUMANS; JANUS KINASE 1; JANUS KINASE 3; JANUS KINASE INHIBITORS; MALE; PIPERIDINES; PYRIMIDINES; PYRROLES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84995890900     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/L16-0125     Document Type: Letter

References (5)

1. Price VH. Treatment of hair loss. N Engl J Med. 1999;341:964-73. [PMID: 10498493]
2. Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14:81-9. [PMID: 25315746] doi:10.1016/j.autrev.2014.10.014
3. Onuora S. Rheumatoid arthritis: can tofacitinib be used as first-line monotherapy for RA? Nat Rev Rheumatol. 2014;10:443. [PMID: 25003770] doi:10 .1038/nrrheum.2014.108
4. Craiglow BG, King BA. Killing two birds with one stone: oral tofacitinib reverses alopecia universalis in a patient with plaque psoriasis [Letter]. J Invest Dermatol. 2014;134:2988-90. [PMID: 24940651] doi:10.1038/jid.2014.260
5. Dhayalan A, King BA. Tofacitinib citrate for the treatment of nail dystrophy associated with alopecia universalis. JAMA Dermatol. 2016;152:492-3. [PMID: 26630079] doi:10.1001/jamadermatol.2015.3772